These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
97 related articles for article (PubMed ID: 13031067)
1. The influence of various sources of nitrogen on the activity of antimicrobial drugs. II. Mycobacterium avium. WEINBERG ED Am Rev Tuberc; 1953 Apr; 67(4):503-8. PubMed ID: 13031067 [No Abstract] [Full Text] [Related]
2. In vitro activity of 12 antimicrobial peptides against Mycobacterium tuberculosis and Mycobacterium avium clinical isolates. Portell-Buj E; Vergara A; Alejo I; López-Gavín A; Monté MR; San Nicolás L; González-Martín J; Tudó G J Med Microbiol; 2019 Feb; 68(2):211-215. PubMed ID: 30570475 [TBL] [Abstract][Full Text] [Related]
3. In vitro susceptibility of Mycobacterium fortuitum, Mycobacterium chelonae and Mycobacterium avium against some quinolones. Casal M; Rodriguez F; Villalba R; Benavente MC; Gonzalez AI Chemioterapia; 1987 Dec; 6(6):431-3. PubMed ID: 3481302 [TBL] [Abstract][Full Text] [Related]
4. [In vitro susceptibilities of Mycobacterium avium and Mycobacterium intracellulare to various drugs]. Tomioka H; Sato K; Saito H Kekkaku; 1991 Jul; 66(7):489-92. PubMed ID: 1890791 [TBL] [Abstract][Full Text] [Related]
5. Chromogenic acid-fast bacilli from human sources. IV. In vitro response to a number of antimicrobial agents on glycerol-blood agar medium. TARSHIS MS; WEED WA; PARKER MV; DUNHAM WB Am Rev Tuberc; 1955 Jul; 72(1):119-22. PubMed ID: 14388215 [No Abstract] [Full Text] [Related]
6. Imidazo[1,2-a]Pyridine-3-Carboxamides Are Active Antimicrobial Agents against Mycobacterium avium Infection In Vivo. Moraski GC; Cheng Y; Cho S; Cramer JW; Godfrey A; Masquelin T; Franzblau SG; Miller MJ; Schorey J Antimicrob Agents Chemother; 2016 Aug; 60(8):5018-22. PubMed ID: 27216051 [TBL] [Abstract][Full Text] [Related]
7. Correlations among naturally occurring resistances to antituberculosis drugs in Mycobacterium avium complex strains. Tsukamura M; Miyachi T Am Rev Respir Dis; 1989 Apr; 139(4):1033-5. PubMed ID: 2930064 [TBL] [Abstract][Full Text] [Related]
8. Preliminary study of the in vitro activity of irloxacin against mycobacteria. Casal M; Gutierrez J; Ruiz P; Moreno G Chemotherapy; 1995; 41(3):204-7. PubMed ID: 7656667 [TBL] [Abstract][Full Text] [Related]
9. [In vitro susceptibilities of Mycobacterium avium and Mycobacterium intracellulare to new macrolides, new quinolones, and antituberculous drugs on Dubos agar medium]. Ogawa K; Miwa T; Sasamoto M; Sasaki T; Tsuda M; Honda K; Furui H; Torii K; Takagi K Kekkaku; 1992 Nov; 67(11):735-8. PubMed ID: 1487866 [TBL] [Abstract][Full Text] [Related]
10. Antituberculosis agents. VI. Activity of a new ciprofloxacin derivative against Mycobacterium avium and some drug-resistant strains of Mycobacterium tuberculosis. Foroumadi A; Soltani F; Moshafi MH Boll Chim Farm; 2002; 141(5):394-6. PubMed ID: 12481384 [TBL] [Abstract][Full Text] [Related]
12. Genetic studies on microbial cross resistance to toxic agents. II. Cross resistance of Micrococcus pyogenes var. aureus to thirty-four antimicrobial drugs. SZYBALSKI W Antibiot Chemother (Northfield); 1953 Nov; 3(11):1095-103. PubMed ID: 24542854 [No Abstract] [Full Text] [Related]
13. [Antimicrobial activity of new quinolones against Mycobacterium avium and Mycobacterium intracellulare determined by the dilution methods using 7H11 agar and Ogawa egg media]. Tomioka H; Sato K; Saito H Kekkaku; 1993 May; 68(5):367-70. PubMed ID: 8331881 [TBL] [Abstract][Full Text] [Related]
14. In Vitro Efficacy of Free and Nanoparticle Formulations of Gallium(III) meso-Tetraphenylporphyrine against Mycobacterium avium and Mycobacterium abscessus and Gallium Biodistribution in Mice. Choi SR; Britigan BE; Switzer B; Hoke T; Moran D; Narayanasamy P Mol Pharm; 2018 Mar; 15(3):1215-1225. PubMed ID: 29421865 [TBL] [Abstract][Full Text] [Related]
15. Antimicrobial susceptibility testing and genotyping of Mycobacterium avium isolates of two tertiary tuberculosis designated hospital, China. Wei G; Huang M; Wang G; Huo F; Dong L; Li Y; Huang H Infect Genet Evol; 2015 Dec; 36():141-146. PubMed ID: 26391006 [TBL] [Abstract][Full Text] [Related]
16. Interaction of antimycobacterial drugs with the anti-Mycobacterium avium complex effects of antimicrobial effectors, reactive oxygen intermediates, reactive nitrogen intermediates, and free fatty acids produced by macrophages. Sano K; Tomioka H; Sato K; Sano C; Kawauchi H; Cai S; Shimizu T Antimicrob Agents Chemother; 2004 Jun; 48(6):2132-9. PubMed ID: 15155211 [TBL] [Abstract][Full Text] [Related]
17. Antimicrobial susceptibility and molecular characterization of Mycobacterium intracellulare in China. Zhao X; Wang Y; Pang Y Infect Genet Evol; 2014 Oct; 27():332-8. PubMed ID: 25131955 [TBL] [Abstract][Full Text] [Related]
18. [The bacteriology of tuberculosis and non-tuberculosis mycobacterial infections]. Wyplosz B; Truffot-Pernot C; Robert J; Jarlier V; Grosset J Rev Mal Respir; 1997 Dec; 14 Suppl 5():S33-48. PubMed ID: 9496590 [TBL] [Abstract][Full Text] [Related]
19. [In vitro antimicrobial activities of quinolones, rifamycins and macrolides against Mycobacterium tuberculosis and M.avium complex: attempt to establish new assay methods which accurately reflect therapeutic effects of test agents in vivo]. Sato K; Tomioka H Kekkaku; 1999 Jan; 74(1):63-70. PubMed ID: 10067057 [TBL] [Abstract][Full Text] [Related]
20. Mycobacterial plasmids: screening and possible relationship to antibiotic resistance in Mycobacterium avium/Mycobacterium intracellulare. Franzblau SG; Takeda T; Nakamura M Microbiol Immunol; 1986; 30(9):903-7. PubMed ID: 3540539 [No Abstract] [Full Text] [Related] [Next] [New Search]